The Association Between Medication Adherence and Health-Related Quality of Life in Patients with COPD: A Cross-Sectional Study
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Purpose: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition with debilitating manifestations that adversely affect patients' health-related quality of life (HRQoL). The clinical course is complicated by patients' low medication adherence level. Low adherence and poor HRQoL are linked to unfavorable disease outcomes. Although many factors affect adherence and HRQoL in COPD, the impact of adherence on HRQoL remain controversial. This study aimed to measure medication adherence and its impact on HRQoL in patients with COPD. Patients and Methods: This cross-sectional observational study included patients with COPD from two health centers in Riyadh, Saudi Arabia. Patients were identified using the medical database and only those fulfilling the GOLD 2020 criteria for COPD diagnosis were recruited. Data were collected via phone interviews and included sociodemographic information, the level of medication adherence assessed using the 5-item Medication Adherence Report Scale (MARS-5), and the HRQoL measured using the St. George Respiratory Questionnaire for COPD (SGRQ-C). Simple and multiple-regression analysis was used to study the factors affecting both parameters and the relation between adherence and HRQoL. Results: The mean MARS-5 score was 21.17± 4.8 (mean ± SD) with only 56.4% of patients with COPD reporting high adherence to their medications. The average total SGRQ score was 51.35 ± 23.82 indicating low HRQoL. Using multiple-regression analysis, comorbidity and intermediate disease duration were associated with lower adherence, while older age, female gender, polypharmacy, and concomitant hypertension predicted lower HRQoL. Moreover, higher adherence to medications was associated with higher overall HRQoL in patients with COPD. Conclusion: Patients with COPD have low medication adherence and low HRQoL. Several patient-, disease-, and therapy-related factors were shown to affect both outcomes; however, higher adherence to medication per se was associated with higher HRQoL in patients with COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additional studies from GCC settings have reported associations between reduced medication adherence and increased ED visits, poorer symptom control, and lower health-related quality of life [10,11].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“More recent evidence by Saja et al. [11] demonstrated that improved medication adherence was associated with better HRQoL outcomes among COPD patients.”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A guideline of selecting and reporting intraclass correlation coefficients for reliability research
Koo, T. K., & Li, M. Y. (2016) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2016.02.012 · Cited by 31,709
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
The St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683 · cited 1×
“40,41 Each item has a specific weight.”
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184
Quality of Life in Chronic Disease Patients
Megari, K. (2013) · Health Psychology Research · doi:10.4081/hpr.2013.932 · Cited by 895 · cited 1×
“21,22 31–33 Several factors influence medication adherence and HRQoL in COPD patients.”
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Chan, A. H. Y., Horne, R., Hankins, M., & Chisari, C. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14193 · Cited by 523
Adherence to inhaled therapy, mortality and hospital admission in COPD
Vestbo, J., Anderson, J. A., Calverley, P. M. A., Celli, B., Ferguson, G. T., Jenkins, C., Knobil, K., Willits, L. R., Yates, J. C., & Jones, P. W. (2009) · Thorax · doi:10.1136/thx.2009.113662 · Cited by 516 · cited 2×
“10,12 Successful management relies heavily on patients’ adherence to their therapeutic plan.”
Bourbeau, J., & Bartlett, S. J. (2008) · Thorax · doi:10.1136/thx.2007.086041 · Cited by 490 · cited 2×
“13,14,47 Using multivariable analysis, several factors were found to be associated with lower adherence including intermediate disease durations, presence of diabetes, and comorbidities, while the presence of disability was associated with higher adherence level.”
Domingo-Salvany, A., Lamarca, R., Ferrer, M., Garcia-Aymerich, J., Alonso, J., Félez, M., Khalaf, A., Marrades, R. M., Monsó, E., Serra-Batlles, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112043 · Cited by 411
Epidemiology and clinical impact of major comorbidities in patients with COPD
Smith, M., & Wrobel, J. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s49621 · Cited by 407 · cited 1×
“49–51 Comorbidities complicate the treatment regimen making it difficult for patients to navigate their medication plan and increase forgetfulness.”
Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease
Osman, I. M., Godden, D. J., Friend, J. A., Legge, J. S., & Douglas, J. G. (1997) · Thorax · doi:10.1136/thx.52.1.67 · Cited by 352 · cited 3×
“18,29,57 The fact that the activity component displayed the worst score in the current study is not surprising given that approximately 80% of COPD patients had comorbidities with more than third suffering from cardiovascular disease limiting patients’ activity.”
Rothrock, N. E., Hays, R. D., Spritzer, K., Yount, S. E., Riley, W., & Cella, D. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.012 · Cited by 351
Meguro, M., Barley, E. A., Spencer, S., & Jones, P. W. (2007) · Chest · doi:10.1378/chest.06-0702 · Cited by 350 · cited 1×
“38 It is a shorter version of the original SGRQ questionnaire.”
Mead, J. (1980) · PubMed · doi:10.1164/arrd.1980.121.2.339 · Cited by 340
Factors Associated With Medication Nonadherence in Patients With COPD
George, J., Kong, D. C. M., Thoman, R., & Stewart, K. (2005) · Chest · doi:10.1378/chest.128.5.3198 · Cited by 321 · cited 3×
“19,44 The positive impact of increasing age on adherence shown by many studies including the current may partially explain the observed difference.”
Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs
Toy, E. L., Beaulieu, N. U., McHale, J. M., Welland, T. R., Plauschinat, C. A., Swensen, A., & Duh, M. S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.006 · Cited by 281
Dietz, P. M., Homa, D., England, L. J., Burley, K., Tong, V. T., Dube, S. R., & Bernert, J. T. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq381 · Cited by 276
Gender and COPD in Patients Attending a Pulmonary Clinic
de Torres, J. P., Casanova, C., Hernández, C., Abreu, J., Aguirre-Jaime, A., & Celli, B. R. (2005) · Chest · doi:10.1378/chest.128.4.2012 · Cited by 255
Is Bronchial Hyperresponsiveness More Frequent in Women than in Men?: A Population-based Study
LEYNAERT, B., BOUSQUET, J., HENRY, C., LIARD, R., & NEUKIRCH, F. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9701060 · Cited by 211
COPD and Cardiovascular Disease
André, S., Conde, B., Fragoso, E., Boléo-Tomé, J. P., Areias, V., Cardoso, J., & Crónica, O. B. O. T. G. D.-G. D. I. N. D. P. O. (2019) · Pulmonology · doi:10.1016/j.pulmoe.2018.09.006 · Cited by 185 · cited 1×
“50,52 Living with a chronic respiratory condition poses a physical and psychological strain on patients due to the progressive limitation it imposes on patients’ day-to-day activities, negatively impacting their HRQoL.”
Lam, C. L., & Lauder, I. J. (2000) · Family Practice · doi:10.1093/fampra/17.2.159 · Cited by 167 · cited 1×
“24,27 The mean total SGRQ of 51.4 ± 23.8 (m±SD) reported in the current study lies within the range reported by other investigators for patients with COPD.”
InfluentialFactors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease
Agh, T., Inotai, A., & Meszaros, A. (2011) · Respiration · doi:10.1159/000324453 · Cited by 157 · cited 2×
“35,36 This does not come as a surprise given the complexity of the relationship.”
Sex differences in lung vulnerability to tobacco smoking
Langhammer, A., Johnsen, R., Gulsvik, A., Holmen, T. L., & Bjermer, L. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00053202 · Cited by 155
Arne, M., Janson, C., Janson, S., Boman, G., Lindqvist, U., Berne, C., & Emtner, M. (2009) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430902808643 · Cited by 155 · cited 1×
“53,54 Unfortunately, patients with COPD score the lowest in overall health and quality of life compared to those with other chronic conditions.”
Medication Adherence Patterns in Chronic Obstructive Pulmonary Disease
Dolce, J. J., Crisp, C., Manzella, B., Richards, J. M., Hardin, J. M., & Bailey, W. C. (1991) · Chest · doi:10.1378/chest.99.4.837 · Cited by 154 · cited 1×
“This figure is in line with those reported by the WHO for chronic conditions and those reported by other investigators for COPD, 14,18,45 but higher than that reported by George et al and Kokturk et al. 12,19 Comparison with other studies is hampered by differences in adherence assessment method…”
Determinants of Different Dimensions of Disease Severity in Asthma and COPD
Wijnhoven, H. A. H., Kriegsman, D. M. W., Hesselink, A. E., Penninx, B. W. J. H., & de Haan, M. (2001) · CHEST Journal · doi:10.1378/chest.119.4.1034 · Cited by 151
Tageldin, M. A., Nafti, S., Khan, J. A., Nejjari, C., Béji, M., Mahboub, B. H., Obeidat, N. M., Uzaslan, E., Sayıner, A., Wali, S., et al. (2012) · Respiratory Medicine · doi:10.1016/s0954-6111(12)70012-4 · Cited by 137 · cited 1×
“George et al reported that 38% of Australian patients with COPD are highly adherent; however, they used a more stringent cutoff of 25 to dichotomize their MARS-5 scale which could explain the lower proportion of highly adherent patients.”
Living with a chronic disease: insights from patients with a low socioeconomic status
Wilder, L. V., Pype, P. F., Mertens, F., Rammant, E., Clays, E., Devleesschauwer, B., Boeckxstaens, P., & Smedt, D. D. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01578-7 · Cited by 135
Simoni, J. M., Wei, Y. J., Qian, J., Zuckerman, I. H., Stuart, B., Shaffer, T., Dalal, A. A., & Bryant‐Comstock, L. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.04.002 · Cited by 131
de-Torres, J. P., Casanova, C., Hernández, C., Abreu, J. A., de Garcini, A. M., Aguirre‐Jaime, A., & Celli, B. R. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-72 · Cited by 129
Chen, Z., Fan, V. S., Belza, B. L., Pike, K. C., & Nguyen, H. Q. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-026oc · Cited by 123
Abdulsalim, S., Unnikrishnan, M. K., Manu, M. K., Alrasheedy, A. A., Godman, B., & Morisky, D. E. (2017) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.10.008 · Cited by 123 · cited 2×
“79 Most patient educational programs focus on newly diagnosed patients where adherence is naturally higher.”
Celli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agusti, A. A., Criner, G. J., MacNee, W., Make, B. J., Rennard, S. I., Stockley, R. A., et al. (2015) · European Respiratory Review · doi:10.1183/16000617.00000315 · Cited by 117
Predictors of Patient Adherence to Long-term Home Nebulizer Therapy for COPD
Turner, J. G., Wright, E. C., Mendella, L., & Anthonisen, N. R. (1995) · CHEST Journal · doi:10.1378/chest.108.2.394 · Cited by 112
Risk Factors and Comorbidities in the Preclinical Stages of Chronic Obstructive Pulmonary Disease
Van Remoortel, H., Hornikx, M., Langer, D., Burtin, C., Everaerts, S., Verhamme, P., Boonen, S., Gosselink, R., Decramer, M., Troosters, T., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1240oc · Cited by 108
The Influence of Informal Caregivers on Adherence in COPD Patients
Trivedi, R. B., Bryson, C. L., Udris, E., & Au, D. H. (2012) · Annals of Behavioral Medicine · doi:10.1007/s12160-012-9355-8 · Cited by 108 · cited 1×
“82 Thus, in addition to dispersing patient educational programs, care should be taken to include informal caregivers in such programs.”
Psychological factors associated with use of home nebulized therapy for COPD
Bosley, C., Corden, Z., Rees, P., & Cochrane, G. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09112346 · Cited by 104 · cited 2×
“A similar positive association between adherence and HRQoL have been demonstrated by some investigators, 12,76 yet others reported either no relation 18,77,78 or, conversely, a negative association.”
Risk factors for chronic obstructive lung disease in Saudi Arabia
Døssing, M., Khan, J. H., & Alrabiah, F. A. (1994) · Respiratory Medicine · doi:10.1016/s0954-6111(05)80334-8 · Cited by 102
Tommelein, E., Mehuys, E., Tongelen, I. V., Brusselle, G., & Boussery, K. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014522982 · Cited by 96 · cited 2×
“19,44 The positive impact of increasing age on adherence shown by many studies including the current may partially explain the observed difference.”
Quality of Life in Different Chronic Diseases and Its Related Factors
Siboni, F. S., Alimoradi, Z., Atashi, V., Alipour, M., & Khatooni, M. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_429_17 · Cited by 91 · cited 1×
“24,27 The mean total SGRQ of 51.4 ± 23.8 (m±SD) reported in the current study lies within the range reported by other investigators for patients with COPD.”
InfluentialPrognostic assessment in COPD: Health related quality of life and the BODE index
Marín, J. M., Côté, C., Orlando Díaz, P., Lisboa, C., Casanova, C., López, M. V., Carrizo, S. J., Pinto-Plata, V., Dordelly, L. J., Nekach, H., et al. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.01.007 · Cited by 87 · cited 1×
“21,22 31–33 Several factors influence medication adherence and HRQoL in COPD patients.”
Alqahtani, J. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268772 · Cited by 76
Ágh, T., Dömötör, P., Bártfai, Z., Inotai, A., Fujsz, E., & Mészáros, Á. (2015) · Respiratory Care · doi:10.4187/respcare.03123 · Cited by 74 · cited 4×
“21 The aim of the current study was to (1) assess the level of medication adherence and HRQoL in patients with COPD, (2) identify the factors affecting them, and (3) examine the relationship between medication adherence and HRQoL in patients with COPD.”
InfluentialEffects of Desert Dust and Sandstorms on Human Health: A Scoping Review
Lwin, K. S., Tobias, A., Chua, P. L., Yuan, L., Thawonmas, R., Ith, S., Htay, Z. W., Yu, L. S., Yamasaki, L., Roqué, M., et al. (2023) · GeoHealth · doi:10.1029/2022gh000728 · Cited by 72
Mueller, S., Wilke, T., Bechtel, B., Punekar, Y. S., Mitzner, K., & Virchow, J. C., Jr. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.11.008 · Cited by 71 · cited 2×
“15 16–20 The growing burden of chronic diseases caused a shift in disease management outlook with more emphasis on improving patients’ health-related quality of life (HRQoL).”
Home Nebulized Therapy for Patients with COPD
Corden, Z. M., Bosley, C., Rees, P. J., & Cochrane, G. M. (1997) · CHEST Journal · doi:10.1378/chest.112.5.1278 · Cited by 69
Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2013) · Diabetes Care · doi:10.2337/dc12-2197 · Cited by 61
Li, T., Cohen, A., Krzyżanowski, M., Zhang, C., Gumy, S., Mudu, P., Pant, P., Liu, Q. S., Kan, H., Tong, S., et al. (2025) · The Lancet Planetary Health · doi:10.1016/s2542-5196(24)00308-5 · Cited by 60
Adherence to COPD treatment in Turkey and Saudi Arabia: Results of the ADCARE study
Kokturk, N., Polatli, M., Oguzulgen, I. K., Saleemi, S., Al Ghobain, M., Khan, J., Doble, A., Tariq, L., Aziz, F., & El Hasnaoui, A. (2018) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s150411 · Cited by 53
Patterns of Cigarette Consumption and Cotinine Levels Among African American Women Smokers
Ahijevych, K., & Wewers, M. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.5.7952545 · Cited by 47
Siu, D. C. H., & Gafni-Lachter, L. (2024) · International Journal of COPD · doi:10.2147/copd.s426050 · Cited by 41 · cited 3×
“13,14,47 Using multivariable analysis, several factors were found to be associated with lower adherence including intermediate disease durations, presence of diabetes, and comorbidities, while the presence of disability was associated with higher adherence level.”
The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study
Ghobain, M. A., Alhamad, E. H., Alorainy, H. S., Kassimi, F. A., Lababidi, H., & Al‐Hajjaj, M. S. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0939 · Cited by 40
Tabyshova, A. K., Sooronbaev, T., Akylbekov, A., Mademilov, M., Isakova, A., Erkinbaeva, A., Magdieva, K., Chavannes, N. H., Postma, M. J., & van Boven, J. F. M. (2022) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-022-00281-z · Cited by 39 · cited 1×
“17,35 Then, as the disease gradually worsens, patients are pressed to adhere to their treatment once again.”
Quality of life in patients with chronic diseases.
Tóthová, V., Bártlová, S., Dolák, F., Kaas, J., Kimmer, D., Maňhalová, J., Martinek, L., & Olišarová, V. (2014) · PubMed · Cited by 38
Alsubaiei, M. E., Cafarella, P., Frith, P. A., McEvoy, R., & Effing, T. (2018) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_293_17 · Cited by 38
Xu, W., Collet, J.-P., Shapiro, S. H., Lin, Y., Yang, T., Wang, C., & Bourbeau, J. (2009) · PubMed · Cited by 35
Instituto de Investigación Sanitaria Gregorio Marañón C/ Dr. Esquerdo, 4. 2. M., Bouza, E., Alvar, A., Almagro, P., Alonso, T., Ancochea, J., Barbé, F., Corbella, J., Gracia, D., Mascarós, E., et al. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/2064.2019 · Cited by 35
Tsiligianni, I., Alma, H. J., de Jong, C., Jelusic, D., Wittmann, M., Schüler, M., Schultz, K., Kollen, B. J., van der Molen, T., & Kocks, J. W. H. (2016) · International Journal of COPD · doi:10.2147/copd.s99793 · Cited by 33 · cited 1×
“18,29,55,56 The disease appeared to affect the “activity” component the most followed by “symptom” and the “impact” components.”
Desert dust and respiratory diseases: Further insights into the epithelial barrier hypothesis
D’Amato, G., & Akdiş, C. A. (2022) · Allergy · doi:10.1111/all.15392 · Cited by 33
Cheruvu, Odhiambo, L. A., Mowls, D. S., Zullo, M. D., & Gudina, A. T. (2016) · International Journal of COPD · doi:10.2147/copd.s106207 · Cited by 31 · cited 1×
“73,74 One of the major goals of the current study was to delineate the effect of medication adherence on patients’ HRQoL.”
Moradkhani, B., Mollazadeh, S., Niloofar, P., Bashiri, A., & Oghazian, M. B. (2021) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-021-00222-x · Cited by 28
Mochizuki, H., Nanjo, Y., & Takahashi, H. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00916.x · Cited by 27
Tangirala, N. C., O’Conor, R. M., Wolf, M. S., Wisnivesky, J. P., & Federman, A. D. (2020) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2020.1712688 · Cited by 23 · cited 1×
“14,43 The average medication adherence level in the current study was 21.57±4.34 (m±SD), which is lower than that reported by other investigators.”
InfluentialChanges in health-related quality of life as a marker in the prognosis in COPD patients
Esteban, C., Aróstegui, I., Arámburu, A., Moraza, J., Aburto, M., Aizpiri, S., Chasco, L., & Quintana, J. M. (2021) · ERJ Open Research · doi:10.1183/23120541.00181-2021 · Cited by 22
Horvat, N., Locatelli, I., Kos, M., & Janežič, A. (2018) · Acta Pharmaceutica · doi:10.2478/acph-2018-0006 · Cited by 19
Almutairi, K. M. (2015) · PubMed · Cited by 18
Quality of Life and Its Predictors among Patients with Selected Chronic Diseases
Qadire, M. I. A., ALHosni, F., Al-Daken, L., Aljezawi, M., Omari, O. A., & Khalaf, A. (2023) · Nursing Forum · doi:10.1155/2023/6657164 · Cited by 18
Khathlan, N. A., Al‐dabbus, Z., Al‐khdir, N., Al‐Matar, M., Al‐Nusaif, S., & Yami, B. H. A. (2021) · Indoor Air · doi:10.1111/ina.12833 · Cited by 14
Arpinelli, F., Carone, M., Gioacchino, R., & Bertolotti, G. (2016) · Multidisciplinary Respiratory Medicine · doi:10.1186/s40248-016-0040-9 · Cited by 13
Havlucu, Y., Yorgancıoğlu, A., Coşkun, A. Ş., & Çelik, P. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.07.89 · Cited by 11 · cited 1×
“21,22 31–33 Several factors influence medication adherence and HRQoL in COPD patients.”
Burden of smoking on quality of life in patients with chronic obstructive pulmonary disease
Galaznik, A., Chapnick, J., Vietri, J., Tripathi, S. V., Zou, K. H., & Makinson, G. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2013.842128 · Cited by 10
Alshehri, S., & Alshibani, M. (2023) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s392946 · Cited by 7 · cited 1×
“15 16–20 The growing burden of chronic diseases caused a shift in disease management outlook with more emphasis on improving patients’ health-related quality of life (HRQoL).”
The dangers of incense burning: COPD in Saudi Arabia
Al‐Kassimi, F. A. (2013) · International Journal of COPD · doi:10.2147/copd.s42057 · Cited by 3
The Effect of Hidden Female Smoking on the Association between Smoking and Asthma
Kim, C. H., & Lee, J. S. (2018) · International Archives of Allergy and Immunology · doi:10.1159/000488677 · Cited by 2
Research works printed but not linked: 4
- Almutairi, 2015, Iran J Public Health, 44, 170
- Tóthová, 2014, Neuro Endocrinol Lett, 35, 11
- 2016, George’s Respiratory Questionnaire for COPD Patients (SGRQ-C) Manual
- Xu, 2009, Int J Tuberc Lung Dis, 13, 181
Cited by
Farhana, L., Rahayu, F. P., Sholihah, S., Sweileh, W. M., Abdulah, R., & Alfian, S. D. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s530503 · Cited by 41
Aldabayan, Y. S., Albarqi, M. N., Alamoudi, F. A., & Elsamahy, I. A. (2026) · BMC Nursing · doi:10.1186/s12912-026-04353-0 · Cited by 1
“The wider adherence literature supports this mechanism: patient–provider communication quality and therapeutic alliance are repeatedly linked to medication adherence and clinical outcomes in chronic illness, including COPD [36].”
Li, X., Ma, X., Qin, W., Shi, C., Liu, L., & Wang, C. (2026) · International Journal of COPD · doi:10.2147/copd.s589904 · Cited by 1
“12,13 Consequently, enhancing inhaler technique, adherence, and overall medication management is essential to improving prognosis.”
Elshafei, A., Safi, I., Aljoaid, A., Alanazi, O., & Almahd, S. (2026) · Healthcare · doi:10.3390/healthcare14131962
Yang, J., Xu, N., & Liang, M. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1720782
Metadata
- Authors
- Saja, M., Younis, A., Alzahrani, L., Alkhlassi, I., Aldakhil, L., Albayyat, R., Alnasser, N., Alokla, K., Alghamdi, L., Rashed, A., & Azer, S.
- Affiliations
- King Saud University (SA)
- King Fahd Medical City (SA)
- Corresponding author
- Saja, Maha
- ORCID
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2025-05
- Volume
- Volume 20
- Pages
- 1567-1583
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- PMC
- PMC12104309
- OpenAlex
- W4410517144
- Semantic Scholar
- 6adb6e70e57e2641fef36b05b4b70dc5fb4944cb
- Cited by
- 10
- References
- 78
- Citations by year
- 2026: 9 · 2025: 1
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of COPD (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- chronic obstructive pulmonary disease, medication adherence, health-related quality of life, MARS-5, St George's Respiratory Questionnaire, comorbidities, disease duration, polypharmacy, hypertension, sociodemographic factors
- MeSH terms
- Aged, Bronchodilator Agents, Cross-Sectional Studies, Female, Humans, Lung, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Risk Factors, Saudi Arabia, Treatment Outcome, Polypharmacy, Pulmonary Disease, Chronic Obstructive, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.